proglumetacin has been researched along with Arthritis, Juvenile Chronic in 1 studies
proglumetacin : A carboxylic ester obtained by formal condensation of the carboxy group of indometacin with the hydroxy group of 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl N(2)-benzoyl-N,N-dipropyl-alpha-glutaminate. Used (as its dimaleate salt) to control pain and inflammation associated with musculoskeletal and joint disorders. Following oral administration, it is metabolised to indometacin and proglumide, a drug with antisecretory effects that helps prevent injury to the stomach lining.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cianfanelli, M | 1 |
| Fiermonte, MA | 1 |
| Fiore, D | 1 |
| Dardano, B | 1 |
| Michela Zucco, FR | 1 |
1 other study available for proglumetacin and Arthritis, Juvenile Chronic
| Article | Year |
|---|---|
[Proglumetacin in the treatment of rheumatoid arthritis and arthrosis].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Arthritis, Rh | 1988 |